Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Orion Biotechnology amylin receptor modulator
- Development stage
- Preclinical
- Lead developer
- Orion Biotechnology
- Modality
- Peptides, Small Molecules
01
Overview
Orion Biotechnology is developing an amylin receptor modulator as part of its GPCR-targeted therapeutic pipeline for the treatment of obesity and metabolic disorders. The program, currently in the discovery and preclinical phase, utilizes the company's proprietary PROcisionX™ platform to create precision-engineered analogs of natural ligands. These analogs are designed to target the amylin receptor, a G protein-coupled receptor (GPCR) involved in satiety and glucose metabolism. While Orion employs both synthetic peptide and small molecule approaches for its GPCR programs, the specific modality for this amylin candidate has not been disclosed.
- Other names
- Amylin program
02
Targets
AMY3 (Amylin receptor 3)AMY (Pancreatic alpha-amylase)
Beyond the preview
Go deeper on Orion Biotechnology amylin receptor modulator.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orion Biotechnology amylin receptor modulator.